Isoxazolidine → 2-[(3,5'-Dichloro-2'-methoxy[1,1'-biphenyl]-4-yl)carbonyl]-isoxazolidine

HRID 1023784Notes

Reaction equation

HRID 1023784 reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C:18]2[CH:23]=[C:22]([Cl:24])[CH:21]=[CH:20][C:19]=2[O:25][CH2:26]C(O)=O)[CH:5]=[CH:6][C:7]=1[C:8]([N:10]1[C@@H:15](C)[CH2:14][CH2:13]C[C@H]1C)=[O:9].[O:30]1CCCN1>>[Cl:1][C:2]1[CH:3]=[C:4]([C:18]2[CH:23]=[C:22]([Cl:24])[CH:21]=[CH:20][C:19]=2[O:25][CH3:26])[CH:5]=[CH:6][C:7]=1[C:8]([N:10]1[CH2:15][CH2:14][CH2:13][O:30]1)=[O:9]

Participants

3

Procedure

The sub-title compound was prepared by the method of example 21 step b) using the product of example 21 step a) and isoxazolidine.

Sources & evidence

ORD record
ord-27cfbd1810774a2e82b36f1e79ce09b9
Source dataset
uspto-grants-2014_05
Patent number
US08722741B2

Reaction notes

Loading…